Venneman M R
Infect Immun. 1972 Mar;5(3):269-82. doi: 10.1128/iai.5.3.269-282.1972.
Immunogenic Salmonella typhimurium ribonucleic acid (RNA) preparations, prepared by differential centrifugation, phenol extraction at 65 C, and ethanol precipitation from 0.5% sodium dodecyl sulfate solution, maintained their immunogenicity through lyophilization. As measured by survival, differential pathogen counts 5 days postchallenge, or clearance of the infecting organism from the tissues, immunization with 50 mug (dry weight) of the lyophilized preparation proved as effective as immunization with 0.1 LD(50) of attenuated S. typhimurium cells. Chromatography of the immunogenic fraction through Biogel P-6 (exclusion limit > 4,600) or through Biogel P-300 (exclusion limit > 300,000) resulted in only one immunogenically active protein of the eluate found in the void volume of the columns. Diethylaminoethyl (DEAE) cellulose anion-exchange chromatography of the RNA preparations showed that the immunogenic activity was eluted from the column at 0.8 to 1.0 m NaCl in a linear 0.1 to 2.0 m NaCl gradient. Nonimmunogenic, protein-containing minor peaks were eluted at 0.1 to 0.5 m NaCl. Serial fractionation of the crude RNA preparations over Biogel P-6 to DEAE cellulose to Biogel P-300 molecular-sieve or anion-exchange columns did not alter the immunogenicity of the RNA preparation. Incorporation of the column fractions into Freund's incomplete adjuvant did not increase their relative effectiveness in eliciting anti-salmonella resistance. Chemical analysis of the immunogenic preparations indicated that they were lacking in detectable protein, lipid, and deoxyribonucleic acid. These results suggest that the immunogenic moiety of the crude nucleic acid fraction is either RNA or an as yet undefined polysaccharide of greater than 300,000 molecular weight.
通过差速离心、65℃苯酚抽提以及从0.5%十二烷基硫酸钠溶液中乙醇沉淀制备的具有免疫原性的鼠伤寒沙门氏菌核糖核酸(RNA)制剂,经冻干后仍保持其免疫原性。通过攻毒后5天的存活情况、差异病原菌计数或组织中感染生物体的清除情况来衡量,用50微克(干重)冻干制剂免疫与用0.1个半数致死量(LD50)的减毒鼠伤寒沙门氏菌细胞免疫一样有效。将免疫原性组分通过Biogel P-6(排阻极限>4600)或Biogel P-300(排阻极限>300000)进行层析,结果在柱的空体积中仅发现一种具有免疫原性活性的洗脱蛋白。RNA制剂的二乙氨基乙基(DEAE)纤维素阴离子交换层析表明,免疫原性活性在0.1至2.0摩尔/升NaCl的线性梯度中于0.8至1.0摩尔/升NaCl处从柱上洗脱下来。非免疫原性的含蛋白质小峰在0.1至0.5摩尔/升NaCl处洗脱。将粗RNA制剂依次通过Biogel P-6至DEAE纤维素再到Biogel P-300分子筛或阴离子交换柱进行分级分离,并未改变RNA制剂的免疫原性。将柱分级组分掺入弗氏不完全佐剂中并不能提高它们在引发抗沙门氏菌抗性方面的相对效力。对免疫原性制剂的化学分析表明,它们缺乏可检测到的蛋白质、脂质和脱氧核糖核酸。这些结果表明,粗核酸组分的免疫原性部分要么是RNA,要么是一种分子量大于300000的尚未明确的多糖。